Schäffler Andréas, Weigert Johanna, Neumeier Markus, Schölmerich Juergen, Buechler Christa
Department of Internal Medicine I, University of Regensburg, D-93042 Regensburg, Germany.
Obesity (Silver Spring). 2007 Feb;15(2):303-13. doi: 10.1038/oby.2007.566.
Collagenous repeat containing sequence of 26-kDa protein (CORS-26) was identified as a new gene transcript expressed in cartilage with unknown function. It was the aim of this study to investigate expression, regulation, and function of CORS-26 in adipocytes.
CORS-26 mRNA and protein expression was studied by reverse transcriptase-polymerase chain reaction, Western blot analysis, and quantitative real-time polymerase chain reaction. Transcriptional regulation was studied by electrophoretic mobility shift assay and luciferase reporter gene assay. The adipocytic secretion of adiponectin and resistin was measured by enzyme-linked immunosorbent assay.
CORS-26 mRNA is absent in 3T3-L1 preadipocytes and adipocytes after 48 hours of differentiation. CORS-26 mRNA was induced from Day 4 to Day 9 of adipocyte differentiation. CORS-26 protein was induced in mature adipocytes. Peroxisome proliferator-activated receptor (PPAR) gamma (but not PPARalpha) in nuclear extracts prepared from adipocytes was shown to bind specifically to a putative peroxisome proliferator response element-one-half-site located at -641/-596 bp. Increasing doses of the ligands troglitazone (1, 10, 20 microM) and fenofibrate (50, 100, 200 microM) but not 15-deoxy-prostaglandin (J(2)) (0.5, 1.0, 2.5 microM) resulted in a significant reduction of both promoter activity and the amount of mRNA expression. Recombinant CORS-26 significantly stimulated the adipocytic secretion of adiponectin and resistin in a dose-dependent manner.
The mRNA and protein expression profile puts CORS-26 in the adipocytokine family. Cartonectin is negatively regulated by exogenous, but not endogenous, PPARgamma ligands. Because CORS-26 up-regulates adipokine secretion, it might be involved in metabolic and immunologic pathways.
含26 kDa蛋白胶原重复序列(CORS-26)被鉴定为软骨中表达的一个功能未知的新基因转录本。本研究旨在探讨CORS-26在脂肪细胞中的表达、调控及功能。
通过逆转录聚合酶链反应、蛋白质印迹分析和定量实时聚合酶链反应研究CORS-26 mRNA和蛋白表达。用电泳迁移率变动分析和荧光素酶报告基因分析研究转录调控。用酶联免疫吸附测定法测量脂联素和抵抗素的脂肪细胞分泌量。
在3T3-L1前脂肪细胞和分化48小时后的脂肪细胞中不存在CORS-26 mRNA。在脂肪细胞分化的第4天到第9天诱导产生CORS-26 mRNA。在成熟脂肪细胞中诱导产生CORS-26蛋白。从脂肪细胞制备的核提取物中的过氧化物酶体增殖物激活受体(PPAR)γ(而非PPARα)显示能特异性结合位于-641/-596 bp处的一个假定的过氧化物酶体增殖物反应元件半位点。增加剂量的曲格列酮(1、10、20 μM)和非诺贝特(50、100、200 μM)配体,但不是15-脱氧前列腺素J2(0.5、1.0、2.5 μM),导致启动子活性和mRNA表达量显著降低。重组CORS-26以剂量依赖方式显著刺激脂联素和抵抗素的脂肪细胞分泌。
mRNA和蛋白表达谱将CORS-26归入脂肪因子家族。外源性而非内源性PPARγ配体对Cartonectin有负调控作用。由于CORS-26上调脂肪因子分泌,它可能参与代谢和免疫途径。